Australia Accepts Three Approval Pathways, Defers Registry For High-Risk Devices
Executive Summary
The Australian government plans to introduce a series of regulatory reforms for devices and drugs over a period of three years, including moves to speed up access to innovative devices and to better leverage assessments by overseas regulators. The changes may include some recovery of costs from industry.
You may also be interested in...
Australia To Make Access To Unauthorized Products Faster And Less Bothersome
New proposals by Australia’s Therapeutic Goods Administration include developing a list of unauthorized medical devices that could be made available to patients faster and more easily. A decision to include a product on the list would not be appealable, the TGA says.
Australia Steps Up Priority Review And Faster Assessment Plans
The Therapeutic Goods Administration is seeking feedback on proposals for a priority-review pathway and a system for designating Australian conformity assessment bodies. Both efforts promise to speed products to market and might also involve new fees for industry.
Australia’s 'Unrealistic' Randomized Controlled Trial Proposal Comes Under Fire
Industry is not entirely happy with the Therapeutic Goods Administration’s proposed guidelines on clinical evidence requirements.